We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
PHF12
SECTIONS
  • TISSUE
  • BRAIN
  • SINGLE CELL TYPE
  • TISSUE CELL TYPE
  • PATHOLOGY
  • DISEASE
  • IMMUNE CELL
  • BLOOD PROTEIN
  • SUBCELLULAR
  • CELL LINE
  • STRUCTURE
  • METABOLIC
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
  • SARS-COV-2
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Patient ID
Tissue
Category
Cluster
Reliability
Brain region
Category
Brain region
Category
Brain region
Category
Reliability
Cell type
Category
Cluster
Tissue
Cell type
Enrichment
Cancer
Prognosis
Cancer
Category
Cell type
Category
Cell lineage
Category
Cluster
Annotation
Disease
Location
Searches
Location
Cell line
Type
Phase
Reliability
Cancer type
Category
Cluster
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Protein structure
In atlas
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • TISSUE CELL

  • PATHOLOGY

  • DISEASE

  • IMMUNE

  • BLOOD

  • SUBCELL

  • CELL LINE

  • STRUCTURE

  • METABOLIC

  • PHF12
CELL LINE
BILE DUCT CANCER BLADDER CANCER BONE CANCER BRAIN CANCER BREAST CANCER CERVICAL CANCER COLORECTAL CANCER ESOPHAGEAL CANCER GALLBLADDER CANCER GASTRIC CANCER
HEAD AND NECK CANCER KIDNEY CANCER LEUKEMIA LIVER CANCER LUNG CANCER LYMPHOMA MYELOMA NEUROBLASTOMA NON-CANCEROUS OVARIAN CANCER
PANCREATIC CANCER PROSTATE CANCER RHABDOID SARCOMA SKIN CANCER TESTIS CANCER THYROID CANCER UNCATEGORIZED UTERINE CANCER
Human cell lines
GENERAL INFORMATIONi

General description of the gene and the encoded protein(s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas project.

Gene namei

Official gene symbol, which is typically a short form of the gene name, according to HGNC.

PHF12
Gene descriptioni

Full gene name according to HGNC.

PHD finger protein 12
Predicted locationi

All transcripts of all genes have been analyzed regarding the location(s) of corresponding protein based on prediction methods for signal peptides and transmembrane regions.

  • Genes with at least one transcript predicted to encode a secreted protein, according to prediction methods or to UniProt location data, have been further annotated and classified with the aim to determine if the corresponding protein(s) are secreted or actually retained in intracellular locations or membrane-attached.

  • Remaining genes, with no transcript predicted to encode a secreted protein, will be assigned the prediction-based location(s).

The annotated location overrules the predicted location, so that a gene encoding a predicted secreted protein that has been annotated as intracellular will have intracellular as the final location.

Read more
Intracellular
Number of transcriptsi

Number of protein-coding transcripts from the gene as defined by Ensembl.

9
HUMAN PROTEIN ATLAS INFORMATIONi

Summary of RNA expression based on cell line data from the DepMap portal and cell line data generated within the Human Protein Atlas project.

Cell line expression clusteri

The RNA data was used to cluster genes according to their expression across cell lines. Clusters contain genes that have similar expression patterns, and each cluster has been manually annotated to describe common features in terms of function and specificity.

Read more
Breast cancer - Unknown function (mainly)
Cell line specificityi

RNA specificity category based on RNA sequencing data from cancer cell lines in the Human Protein Atlas grouped according to type of cancer. Genes are classified into six different categories (enriched, group enriched, enhanced, low specificity and not detected) according to their RNA expression levels across the panel of cell lines.

Read more
Low cancer specificity
Tau specificity scorei

Tau specificity score is a numerical indicator of the specificity of the gene expression across cells or tissues. The value ranges from 0 and 1, where 0 indicates identical expression across all cells/tissue types, while 1 indicates expression in a single cell/tissue type.

Read more
0.12
Cell line distributioni

RNA distribution category based on RNA sequencing data from cancer cell lines in the Human Protein Atlas grouped according to type of cancer. Genes are classified into five different categories (detected in all, detected in many, detected in some, detected in single and not detected) according to their pattern of detected RNA expression across the panel of cell lines.

Read more
Detected in all
Protein evidencei

Evidence score for genes based on UniProt protein existence (UniProt evidence); a Human Protein Atlas antibody- or RNA based score (HPA evidence); and evidence based on PeptideAtlas (MS evidence). The avaliable scores are evidence at protein level, evidence at transcript level, no evidence, or not avaliable.

Read more
Evidence at protein level
CELL LINESi

RNA expression data as normalized transcript per million (nTPM) values of cancer cell lines.The analyzed cell lines are grouped according to cancer type. Detailed information about the groups is revealed by hovering over the corresponding bar in the chart. More information and cell line data can be found in the Cell line section.

Read more
Cell line categories
Alphabetical
Expression
RNA specificity:Low cancer specificity

EXPRESSION CLUSTERING & CORRELATIONi

The RNA data was used to cluster genes according to their expression across samples. The resulting clusters have been manually annotated to describe common features in terms of function and specificity. The annotation of the cluster is displayed together with a confidence score of the gene's assignment to the cluster. The confidence is calculated as the fraction of times the gene was assigned to this cluster in repeated calculations and is reported between 0 to 1, where 1 is the highest possible confidence. The clustering results are shown in a UMAP, where the cluster this gene was assigned to is highlighted as a colored area in which most of the cluster genes reside. A table shows the 15 most similar genes in terms of expression profile.

Read more
PHF12 is part of cluster 65 Breast cancer - Unknown function with confidencei

Confidence is the fraction of times a gene was assigned to the cluster in repeated clustering, and therefore reflects how strongly associated it is to the cluster. A confidence of 1 indicates that the gene was assigned to this cluster in all repeated clusterings.

Read more
1
581 genes in cluster
Go to interactive expression cluster page
15 nearest neighbours based on cell line RNA expression
Neighbouri

Gene name according to HGNC.

Descriptioni

Gene description according to HGNC.

Correlationi

Correlation between the selected gene and neighboring gene. Correlation is calculated as Spearman correlation in PCA space based on the RNA-seq expression data.

Read more
Clusteri

ID of the expression cluster of the neighboring gene.

Read more
SUPT6H SPT6 homolog, histone chaperone and transcription elongation factor 0.5356 65
PIP4K2B Phosphatidylinositol-5-phosphate 4-kinase type 2 beta 0.5014 65
RUNDC1 RUN domain containing 1 0.4690 65
ERAL1 Era like 12S mitochondrial rRNA chaperone 1 0.4395 65
SEC16A SEC16 homolog A, endoplasmic reticulum export factor 0.4394 55
CWC25 CWC25 spliceosome associated protein homolog 0.4368 65
KIAA0100 KIAA0100 0.4324 65
MARK2 Microtubule affinity regulating kinase 2 0.4282 58
TAOK1 TAO kinase 1 0.4268 65
TBC1D3L TBC1 domain family member 3L 0.4161 60
NUFIP2 Nuclear FMR1 interacting protein 2 0.4134 65
FBXL20 F-box and leucine rich repeat protein 20 0.4126 65
MED1 Mediator complex subunit 1 0.4111 65
PPEF2 Protein phosphatase with EF-hand domain 2 0.4019 65
PCGF2 Polycomb group ring finger 2 0.4015 65

CELL LINE DATA
Alphabetical
Expression
Bile duct cancer (n=7)
Alphabetical
Expression
Bladder cancer (n=26)
Alphabetical
Expression
Bone cancer (n=19)
Alphabetical
Expression
Brain cancer (n=65)
Alphabetical
Expression
Breast cancer (n=50)
Alphabetical
Expression
Cervical cancer (n=3)
Alphabetical
Expression
Colorectal cancer (n=57)
Alphabetical
Expression
Esophageal cancer (n=27)
Alphabetical
Expression
Gallbladder cancer (n=1)
Alphabetical
Expression
Gastric cancer (n=38)
Alphabetical
Expression
Head and Neck cancer (n=33)
Alphabetical
Expression
Kidney cancer (n=31)
Alphabetical
Expression
Leukemia (n=88)
Alphabetical
Expression
Liver cancer (n=24)
Alphabetical
Expression
Lung cancer (n=196)
Alphabetical
Expression
Lymphoma (n=57)
Alphabetical
Expression
Myeloma (n=34)
Alphabetical
Expression
Neuroblastoma (n=17)
Alphabetical
Expression
Non-cancerous (n=60)
Alphabetical
Expression
Ovarian cancer (n=46)
Alphabetical
Expression
Pancreatic cancer (n=41)
Alphabetical
Expression
Prostate cancer (n=7)
Alphabetical
Expression
Rhabdoid (n=14)
Alphabetical
Expression
Sarcoma (n=14)
Alphabetical
Expression
Skin cancer (n=50)
Alphabetical
Expression
Testis cancer (n=1)
Alphabetical
Expression
Thyroid cancer (n=11)
Alphabetical
Expression
Uncategorized (n=10)
Alphabetical
Expression
Uterine cancer (n=28)

Contact

  • NEWS ARTICLES
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.